False-positive extended-spectrum β-lactamase tests for Klebsiella oxytoca srtrains hyperproducing K1 β-lactamase [2]

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 3, 2004, Pages 545-547

  Potz, Nicola A C ^a   Colman, Melissa ^a   Warner, Marina ^a   Reynolds, Rosy ^b   Livermore, David M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b British Soc Antimicrob Chemother   (United Kingdom)

Author keywords

Cefepime; Cefotaxime; Ceftazidime; Celpodoxime; Interpretation of ESBL test results

Indexed keywords

BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CLAVULANIC ACID; PIPERACILLIN PLUS TAZOBACTAM;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; CONTROLLED STUDY; DIAGNOSTIC ERROR; ENTEROBACTER; ENTEROBACTERIACEAE; ENZYME ASSAY; ENZYME SUBSTRATE; ENZYME SYNTHESIS; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORIN RESISTANCE; CLAVULANIC ACID; FALSE POSITIVE REACTIONS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA OXYTOCA; MICROBIAL SENSITIVITY TESTS;

EID: 1642413533     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh112     Document Type: Letter

References (6)

1. Andrews, J. (2003). Detection of extended-spectrum β-lactamases (ESBLs) in E. coli and Klebsiella species. [Online.] http://www.bsac.org.uk/uploads/Ecoliklebsiella.pdf (12 December 2003, date last accessed).
2. Thomson, K. S. (2001). Controversies about extended-spectrum and AmpC β-lactamases. Emerging Infectious Diseases 7, 333-6.
3. Andrews, J. M. (2001). Determination of minimum inhibitory concentrations. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 5-16.
4. Livermore, D. M. & Brown, D. F. J. (2001). Detection of β-lactamase-mediated resistance. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 59-64.
5. Midolo, P. D., Matthews, D., Fernandez, C. D. et al. (2002). Detection of extended spectrum β-lactamases in the routine clinical microbiology laboratory. Pathology 34, 362-4.
6. Sturenburg, E., Sobottka, I., Feucht, H.-H. et al. (2003). Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum β-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. Diagnostic Microbiology and Infectious Disease 45, 29-34.